Micelles co-delivering OVA antigen with plasmid DNA encoding CCR7 have also been used to encourage DC migration to LNs through upregulation of CCR7 by DCs transfected with the plasmid at the local injection site, resulting in increased CD8 T cell priming that improves tumor control (108). The gene discussed is CD8A; the disease is neoplasm.